Janssen-Cilag AG - Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung | | 66135 | | 01 | | Stelara 130 mg | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC05 | | Ustekinumab | | 02.06.2017 | | |
| Composition | ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dinatrii edetas, methioninum, aqua ad iniectabile q.s. ad solutionem pro 26 ml, natrium 2.5 µg/ml. | Packungsbestandteile | | Concentrate for infusion | | | | | | Active Agent | Dose |
---|
Ustekinumabum | 130mg / 26ml |
| BAG: Active Agent | Dose |
---|
Ustekinumabum | 130 mg |
| | Inactive agents |
---|
Dinatrii Edetas | Histidin Hydrochloride Monohydrate | Histidine | Methionine | Polysorbatum 80 | Saccharum |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | | 3074.64 | 3360.25 | B | SL | Yes |
|
|